These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33755462)

  • 1. Expedient Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
    Rhoades D; Rheingold AL; O'Malley BW; Wang J
    J Am Chem Soc; 2021 Apr; 143(13):4915-4920. PubMed ID: 33755462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total Syntheses of Pladienolide-Derived Spliceosome Modulators.
    Sim J; Jang E; Kim HJ; Jeon H
    Molecules; 2021 Sep; 26(19):. PubMed ID: 34641481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enantioselective total synthesis of pladienolide B: a potent spliceosome inhibitor.
    Ghosh AK; Anderson DD
    Org Lett; 2012 Sep; 14(18):4730-3. PubMed ID: 22954141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enantioselective synthesis of pladienolide B and truncated analogues as new anticancer agents.
    Kumar VP; Chandrasekhar S
    Org Lett; 2013 Jul; 15(14):3610-3. PubMed ID: 23822896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total Synthesis of the Spliceosome Modulator Pladienolide B via Asymmetric Alcohol-Mediated syn- and anti-Diastereoselective Carbonyl Crotylation.
    Yoo M; Krische MJ
    Angew Chem Int Ed Engl; 2021 Jun; 60(25):13923-13928. PubMed ID: 33794050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic entry to pladienolide B and FD-895.
    Mandel AL; Jones BD; La Clair JJ; Burkart MD
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5159-64. PubMed ID: 17681759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the spliceosome in chronic lymphocytic leukemia with the macrolides FD-895 and pladienolide-B.
    Kashyap MK; Kumar D; Villa R; La Clair JJ; Benner C; Sasik R; Jones H; Ghia EM; Rassenti LZ; Kipps TJ; Burkart MD; Castro JE
    Haematologica; 2015 Jul; 100(7):945-54. PubMed ID: 25862704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the macrocyclic core of (-)-pladienolide B.
    Skaanderup PR; Jensen T
    Org Lett; 2008 Jul; 10(13):2821-4. PubMed ID: 18510332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total synthesis of the potent antitumor macrolides pladienolide B and D.
    Kanada RM; Itoh D; Nagai M; Niijima J; Asai N; Mizui Y; Abe S; Kotake Y
    Angew Chem Int Ed Engl; 2007; 46(23):4350-5. PubMed ID: 17437311
    [No Abstract]   [Full Text] [Related]  

  • 10. Test-firing ammunition for spliceosome inhibition in cancer.
    Dehm SM
    Clin Cancer Res; 2013 Nov; 19(22):6064-6. PubMed ID: 24097858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
    Suda K; Rozeboom L; Yu H; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
    PLoS One; 2017; 12(2):e0172209. PubMed ID: 28192473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor compounds based on a natural product consensus pharmacophore.
    Lagisetti C; Pourpak A; Jiang Q; Cui X; Goronga T; Morris SW; Webb TR
    J Med Chem; 2008 Oct; 51(19):6220-4. PubMed ID: 18788726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives.
    Lagisetti C; Yermolina MV; Sharma LK; Palacios G; Prigaro BJ; Webb TR
    ACS Chem Biol; 2014 Mar; 9(3):643-8. PubMed ID: 24377313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cryo-EM structure of the SF3b spliceosome complex bound to a splicing modulator reveals a pre-mRNA substrate competitive mechanism of action.
    Finci LI; Zhang X; Huang X; Zhou Q; Tsai J; Teng T; Agrawal A; Chan B; Irwin S; Karr C; Cook A; Zhu P; Reynolds D; Smith PG; Fekkes P; Buonamici S; Larsen NA
    Genes Dev; 2018 Feb; 32(3-4):309-320. PubMed ID: 29491137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spliceosome inhibitors isoginkgetin and pladienolide B induce ATF3-dependent cell death.
    Vanzyl EJ; Sayed H; Blackmore AB; Rick KRC; Fernando P; McKay BC
    PLoS One; 2020; 15(12):e0224953. PubMed ID: 33370278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.
    Vanzyl EJ; Rick KRC; Blackmore AB; MacFarlane EM; McKay BC
    PLoS One; 2018; 13(1):e0191178. PubMed ID: 29338026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spliceostatins and Derivatives: Chemical Syntheses and Biological Properties of Potent Splicing Inhibitors.
    Ghosh AK; Mishevich JL; Jurica MS
    J Nat Prod; 2021 May; 84(5):1681-1706. PubMed ID: 33974423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of (+)-18-epi-latrunculol A: development of a synthetic route.
    Williams BD; Smith AB
    J Org Chem; 2014 Oct; 79(19):9284-96. PubMed ID: 25243951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Carbohydrate-Derived Splice Modulator.
    Dhar S; La Clair JJ; León B; Hammons JC; Yu Z; Kashyap MK; Castro JE; Burkart MD
    J Am Chem Soc; 2016 Apr; 138(15):5063-8. PubMed ID: 27058259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis of bryostatin 3.
    Trost BM; Wang Y; Buckl AK; Huang Z; Nguyen MH; Kuzmina O
    Science; 2020 May; 368(6494):1007-1011. PubMed ID: 32467391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.